Inhibitors of pyruvate kinase as therapeutic agents for cancer

Invention Grant

US08026278B2 Inhibitors of pyruvate kinase as therapeutic agents for cancer 有权

Title translation: 丙酮酸激酶作为癌症治疗剂的抑制剂

Please log in to see more content

Patent Title: Inhibitors of pyruvate kinase as therapeutic agents for cancer
Patent Title (中): 丙酮酸激酶作为癌症治疗剂的抑制剂
Application No.: US11915664

Application Date: 2006-05-29
Publication No.: US08026278B2

Publication Date: 2011-09-27
Inventor: Brian R. Smith , Tak-Hang Chan , Brian Leyland-Jones
Applicant: Brian R. Smith , Tak-Hang Chan , Brian Leyland-Jones
Agency: Benoît & Côté
International Application: PCT/CA2006/000871 WO 20060529
International Announcement: WO2006/125323 WO 20061130
Main IPC: A01K31/215
IPC: A01K31/215

Inhibitors of pyruvate kinase as therapeutic agents for cancer

Abstract:

The present invention relates to compounds for the inhibition of pyruvate kinase and ATP production which are capable of inhibiting cancer cells proliferation.

Abstract(Chinese):

本发明涉及能够抑制癌细胞增殖的抑制丙酮酸激酶和ATP产生的化合物。

Public/Granted literature

US20080311183A1 Novel Inhibitors of Pyruvate Kinase as Therapeutic Agents for Cancer Public/Granted day:2008-12-18

Information query

Espacenet